COSCIENS Biopharma Inc. Estimated Financial Effect Of Contingent Liabilities
COSCIENS Biopharma Inc. (CSCIF) had Estimated Financial Effect Of Contingent Liabilities of $0 as of 2018-12-31, per its 20-F filed 2019-04-01.
Discontinued › Notes
ifrs-full:EstimatedFinancialEffectOfContingentLiabilities · last filed 2019-04-01
- 2018-12-31: Estimated Financial Effect Of Contingent Liabilities $0.00.
- 2017-12-31: Estimated Financial Effect Of Contingent Liabilities $0.00.
- 2016-12-31: Estimated Financial Effect Of Contingent Liabilities $0.00.
| Period end | Estimated Financial Effect Of Contingent Liabilities |
|---|---|
| 2018-12-31 | $0.00 20-F · filed 2019-04-01 |
| 2017-12-31 | $0.00 20-F · filed 2019-04-01 |
| 2016-12-31 | $0.00 20-F · filed 2018-03-28 |